Peter Feinberg - Sep 13, 2021 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg
Stock symbol
IMRX
Transactions as of
Sep 13, 2021
Transactions value $
$131,114
Form type
4
Date filed
9/15/2021, 05:58 PM
Previous filing
Aug 4, 2021
Next filing
Sep 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $124K +5.75K +1.49% $21.51 392K Sep 13, 2021 General Partner of PF Associates L.P. F1
transaction IMRX Class A Common Stock Purchase $7.42K +349 $21.25 349 Sep 13, 2021 Direct F2
holding IMRX Class A Common Stock 477K Sep 13, 2021 General Partner of PEF LLC.
holding IMRX Class A Common Stock 115K Sep 13, 2021 General Partner of S4K Investments LLC.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.08 to $22.00. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.
F2 This transaction was executed in multiple trades through a broker-dealer at a price of $21.25. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.